Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28596
Title: | Automated processing of solid target 86Y using enriched SrO powder. | Austin Authors: | Dinh, Thien;Panopoulos, Harris;Poniger, Stan ;Scott, Andrew M | Affiliation: | Molecular Imaging and Therapy Olivia Newton-John Cancer Research Institute Faculty of Medicine, University of Melbourne, Melbourne, Australia School of Cancer Medicine, La Trobe University, Melbourne, Australia |
Issue Date: | Mar-2022 | Date: | 2021-12-28 | Publication information: | Applied Radiation and Isotopes 2022; 181: 110052 | Abstract: | 86Y (t1/2 = 14.74 h, 32% β+) has significant potential in theranostic applications as a simultaneous PET imaging partner to 90Y-labelled antibody therapy. However, the complex and costly nature of producing 86Y has led to this radiometal being difficult for hospitals and researchers to obtain. The aim of this work was to develop a simple and cost-efficient method for safely producing 86Y. Our approach was twofold: to develop a method of target preparation that would significantly increase the cost efficiency of producing 86Y, and to design and construct an automated purification system that would eliminate manual radiation handling risks and exposure. Multiple automated productions of high radionuclidic purity (99.45%) 86Y were performed resulting in saturation yields of between 518 MBq/μA and 1332 MBq/μA, dependent on target thickness. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28596 | DOI: | 10.1016/j.apradiso.2021.110052 | ORCID: | 0000-0002-6656-295X 0000-0001-5208-8225 |
Journal: | Applied Radiation and Isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine | PubMed URL: | 35032841 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35032841/ | Type: | Journal Article | Subjects: | Cyclotron Isotope Solid target Yttrium-86 |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.